Market Overview:
The global diabetes insulin pumps market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in insulin pumps, and rising awareness about diabetes management. Based on type, the global diabetes insulin pumps market is segmented into tethered pumps and patch pumps. Tethered pump held a larger share of the market in 2017 owing to their longer battery life as compared to patch pumps and their ability to provide more accurate dosage control as compared to patch pumps. However, with technological advancements being made in the field of patch pump technology, this segment is expected witness high growth during the forecast period from 2018-2030. Based on application, the global diabetes insulin pump market is segmented into type I diabetes and type II diabetes. Type I Diabetes held a larger share of this market in 2017 due its higher prevalence as compared o type II Diabetes . However , with increasing incidence rates for both types of diabetics across all regions , thi s segmen t i s expec ted t o gr ow at a hig her cagr duri ng th e for es ti mated pe riod .
Product Definition:
Insulin pumps are devices that deliver insulin under the skin. They have a small tube called a cannula that is inserted just below the skin surface. The pump is attached to a reservoir of insulin that holds several days' worth of insulin. The pump continuously delivers very small amounts of insulin through the cannula into the subcutaneous tissue, where it is absorbed by the body.
Tethered Pumps:
Tethered pumps are also known as insulin pumps. They are battery-powered medical devices that assist in the delivery of human insulin through subcutaneous canulation by measuring blood glucose levels. The major advantage of these devices is that they can be used for longer durations and with greater ease than conventional methods such as injections, which require frequent change of supplies of human insulin.
Patch Pumps:
A patch pump is a small portable device that can be used to deliver any medication, including insulin. It's an alternative to continuous glucose monitoring (CGM) devices as it allows patients to move around and perform their daily activities while still being able to take care of their diabetes. The main advantages of using a patch pump are the convenience and flexibility it offers in terms of usage.
Application Insights:
The application segment includes type I and other diabetes. Type I diabetes, formerly known as juvenile or insulin-dependent diabetes has a high prevalence rate and is expected to grow at the fastest rate during the forecast period. This can be attributed to increasing cases of obesity among children and adolescents coupled with lack of physical activity leading to unhealthy dietary habits including fast food and sugary drinks which leads to excessive calorie consumption resulting in weight gain around puberty along with insufficient production of insulin by the body due to deficiency in beta cells of pancreas resulting in hyperglycemia. Insulin pumps are considered a better alternative for patients suffering from type I as well as other forms of diabetes since they automate several processes involved in delivering insulin such as measuring blood glucose levels, dispensing required amount of insulin per day, maintaining proper fluid balance while reducing risks associated with hypoglycemia & hyperglycemia.
Regional Analysis:
North America dominated the global market in 2017. High adoption of advanced medical devices, presence of well-established healthcare infrastructure and high disease prevalence are some factors contributing to its growth. Furthermore, increasing number of product launches by key companies is also expected to drive the region’s growth over the forecast period. For instance, in May 2018, Medtronic launched two new insulin pumps under brand name ‘Lantus Next Generation Insulin Pump’ and ‘Tandem Tritium X2A System’ for Type I & II diabetes patients respectively.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for insulin pumps in the coming years.
- Growing awareness about insulin pumps: There is a growing awareness among people about the benefits of using insulin pumps over other modes of treatment for diabetes. This is likely to boost the demand for these devices in the near future.
- Technological advancements: The manufacturers are constantly working on developing new and innovative technologies that can make insulin pumps more user-friendly and easier to use. This is likely to spur growth in this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Insulin Pumps Market Research Report
By Type
Tethered Pumps, Patch Pumps
By Application
Type I Diabetes, Type II Diabetes
By Companies
Medtronic, Roche, Johnson & Johnson, Insulet Corp, Tandem Diabetes care, Valeritas, SOOIL, Microport
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Insulin Pumps Market Report Segments:
The global Diabetes Insulin Pumps market is segmented on the basis of:
Types
Tethered Pumps, Patch Pumps
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Type I Diabetes, Type II Diabetes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Roche
- Johnson & Johnson
- Insulet Corp
- Tandem Diabetes care
- Valeritas
- SOOIL
- Microport
Highlights of The Diabetes Insulin Pumps Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tethered Pumps
- Patch Pumps
- By Application:
- Type I Diabetes
- Type II Diabetes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Insulin Pumps Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A diabetes insulin pump is a medical device that helps people with diabetes control their blood sugar levels by delivering insulin through a small tube inserted under the skin in the stomach. The pump continuously delivers insulin to keep blood sugar levels within a target range.
Some of the major companies in the diabetes insulin pumps market are Medtronic, Roche, Johnson & Johnson, Insulet Corp, Tandem Diabetes care, Valeritas, SOOIL, Microport.
The diabetes insulin pumps market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetes Insulin Pumps Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diabetes Insulin Pumps Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diabetes Insulin Pumps Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diabetes Insulin Pumps Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diabetes Insulin Pumps Market Size & Forecast, 2020-2028
4.5.1 Diabetes Insulin Pumps Market Size and Y-o-Y Growth
4.5.2 Diabetes Insulin Pumps Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tethered Pumps
5.2.2 Patch Pumps
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Type I Diabetes
6.2.2 Type II Diabetes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetes Insulin Pumps Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetes Insulin Pumps Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tethered Pumps
9.6.2 Patch Pumps
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Type I Diabetes
9.10.2 Type II Diabetes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tethered Pumps
10.6.2 Patch Pumps
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Type I Diabetes
10.10.2 Type II Diabetes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tethered Pumps
11.6.2 Patch Pumps
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Type I Diabetes
11.10.2 Type II Diabetes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tethered Pumps
12.6.2 Patch Pumps
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Type I Diabetes
12.10.2 Type II Diabetes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tethered Pumps
13.6.2 Patch Pumps
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Type I Diabetes
13.10.2 Type II Diabetes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetes Insulin Pumps Market: Competitive Dashboard
14.2 Global Diabetes Insulin Pumps Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Roche
14.3.3 Johnson & Johnson
14.3.4 Insulet Corp
14.3.5 Tandem Diabetes care
14.3.6 Valeritas
14.3.7 SOOIL
14.3.8 Microport
